article thumbnail

A Bold Goal: Reshoring 25% of Small Molecule API to the U.S. in 5 Years – APIIC’s Report to The White House

FDA Law

Industry should leverage existing technologies while furthering research and development of innovative and disruptive technologies, in partnership with academia and government. A single public entity should coordinate the public-private partnerships established as part of this national strategy.